Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
about
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practiceWhat therapies have replaced rofecoxib in Ireland?Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Characterizing new users of NSAIDs before and after rofecoxib withdrawal.Medical evidence and health policy: a marriage of convenience? The case of proton pump inhibitors.Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
P2860
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@ast
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@en
type
label
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@ast
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@en
prefLabel
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@ast
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@en
P2093
P2860
P1476
Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
@en
P2093
John Feely
Kathleen Bennett
Mary Teeling
P2860
P304
P356
10.1046/J.1365-2125.2003.02012.X
P407
P577
2004-03-01T00:00:00Z